U.S. Oil and Gas Stock News

Coca-Cola FEMSA. de stock has delivered a 120.8% total return over the past 5 years, and today its intrinsic value estimate using a Discounted Cash Flow (DCF) approach points to the shares trading at a discount, while earnings based multiples send a similar undervalued signal. A 120.8% gain over 5 years suggests Coca-Cola FEMSA. de has already rewarded long term shareholders, so any valuation gap now matters more to fresh capital. For the current price to align with the intrinsic value...

Thermo Fisher Scientific (TMO) has just posted its Q2 2026 numbers, with revenue of about US$12.0 billion and basic EPS of US$4.68 helping to shape how investors assess the latest half year, while trailing 12 month EPS sits at US$18.63 on revenue of roughly US$46.3 billion. Over the past few quarters, revenue has moved from US$10.9 billion in Q2 2025 to US$12.0 billion in Q2 2026, and quarterly basic EPS has shifted from US$4.28 to US$4.68. This sets up a results season where margins and...

China's market regulator has imposed a major antitrust fine on Trip.com Group (NasdaqGS:TCOM) related to hotel booking practices. Authorities found the company used exclusive arrangements and technical measures that allegedly restricted competition in online hotel distribution. The decision includes corrective requirements aimed at changing how Trip.com Group works with hotel partners and manages platform access. Trip.com Group is a leading online travel services provider, with hotel...

Sunrun (NasdaqGS:RUN) is expanding its Californian distributed power plant to support the state grid with 425 MW of peak capacity. The virtual power plant now spans more than 80,000 households equipped with residential battery systems. The portfolio is integrating with two major state grid service programs to provide utility scale support from distributed resources. Sunrun sits at the intersection of residential solar, battery storage, and grid services, and this expanded virtual power...

Zevra Therapeutics (ZVRA) is back in focus after the European Medicines Agency’s CHMP issued a negative opinion on arimoclomol for Niemann Pick disease type C, prompting a planned re examination and a sharp share price reaction. See our latest analysis for Zevra Therapeutics. The CHMP setback has hit sentiment hard in the short term, with Zevra Therapeutics’ share price down 23.92% over one day and 27.18% over 30 days. However, its year to date share price return of 14.21% and three year...

Republic Services stock has nearly doubled over the past five years, yet the valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples make the shares look expensive. Republic Services has returned about 95.2% over five years, which puts longer term holders in a strong position even though the stock is down 10.5% over the last year. Steady cash flow generation from waste collection and disposal contracts can...

Ultra Clean Holdings stock has delivered a very large 1 year return, yet the valuation picture appears more balanced. The intrinsic value estimate from a Discounted Cash Flow (DCF) model is close to the current share price, while market-based multiples still point to some undervaluation. Ultra Clean Holdings is up about 287.1% over the past year, which puts extra focus on whether the current price still leaves enough valuation cushion. Expectations for continued cash flow generation from its...

Paramount Skydance (PSKY) is back in focus after Discovery affiliates extended the tender and exchange offer deadlines for Warner Bros. Discovery notes. These notes will be swapped into new Paramount debt, in connection with the pending Warner Bros. Discovery acquisition. See our latest analysis for Paramount Skydance. Despite the recent regulatory approvals and the extended debt tender and exchange offers, Paramount Skydance's short term momentum has been weak, with the share price down...

The recent Nvidia and SK Hynix agreement for high bandwidth memory and massive data center capacity has pushed AI hardware and infrastructure back into the spotlight, and it could reshape how investors think about the companies that supply the core building blocks for advanced computing. This kind of long term supply deal and planned 2 gigawatt data center buildout signal that the demand story around AI infrastructure is not just a short term headline. In this article, you will see 3 stocks...

Ardagh Metal Packaging (NYSE:AMBP) has reported Q2 2026 results with revenue of US$1.7 billion and basic EPS of US$0.06, alongside net income of US$35 million, while the trailing twelve months show revenue of US$6.0 billion and EPS of US$0.03. Over the past few quarters, the company has seen revenue move from US$1.5 billion in Q1 2026 and US$1.3 billion in Q4 2025 to the latest US$1.7 billion print, with EPS and net income shifting between small profits and losses over that period. For...

The launch of the world’s largest commercial sand battery in Finland has pushed thermal energy storage from a niche concept into a real world test of what comes next for renewable power, heating, and traditional fuel supply chains. For investors, the news underscores how quickly expectations can shift for companies tied to lithium, wood based fuels, and large scale district energy systems. This article examines three stocks with exposure to the sand battery story, one that could be positioned...

Fidelity National Information Services has had a tough run, with the share price down about 68.4% over the past five years, yet its current valuation checks still lean towards the stock looking cheap on several measures. Over five years the stock has declined 68.4%, which means long term holders have seen a significant erosion in market value. Industry recognition for FIS' credit and risk technology, including recent awards for AI embedded risk tools and lending platforms, can support...

The Fed’s recent shift under Kevin Warsh toward possible rate hikes, a higher 2026 rate forecast, and less predictable guidance has put short-duration fixed income and cash equivalents back in the spotlight. With policy rates staying elevated and the prospect of a steeper yield curve, investors are rethinking where to park capital that seeks income while keeping interest rate sensitivity contained. This article looks at how that backdrop connects to a curated screener of large, financially...

Broadridge Financial Solutions stock has fallen 40.1% over the past year, yet its valuation checks and market multiples together point to a picture that is closer to mixed than clearly cheap. The share price decline of 40.1% over the last 12 months raises the question of whether sentiment has moved further than the underlying value. Broadridge Financial Solutions' recent work around tokenized assets may support long term growth expectations, while the risk is that execution or adoption of...

In July 2026, Regions Financial Corporation reported second-quarter results showing year-on-year increases in net interest income to US$1,277 million and net income to US$570 million, while also continuing share repurchases and declaring higher common and preferred dividends. The 13% rise in the common dividend, alongside steady earnings growth and lower net loan charge-offs of US$102 million, underscores management’s willingness to return more capital to shareholders while maintaining...

Emerson Electric stock has delivered a strong 71.8% return over the past three years. At around US$147.94 and with a mixed valuation score, it no longer looks like an obvious bargain or an obvious excess. Over the last three years, Emerson Electric has returned 71.8%, which puts recent performance firmly in the positive column and raises the bar for what counts as good value today. New automation software for refinery scheduling can support expectations for profitability. At the same time,...

Arcosa (NYSE:ACA) has agreed to be acquired 100% by CRH in an all cash merger. The transaction is subject to approval by Arcosa stockholders and relevant regulators. If completed, Arcosa stockholders would receive cash consideration for their shares instead of continuing equity in the company. Arcosa is a provider of infrastructure related products and solutions, so this proposed acquisition by CRH is within a sector that continues to attract attention from large industrial and materials...

DRDGOLD (NYSE:DRD) has drawn fresh investor interest after appointing experienced chartered accountant Mark Hoffman as an independent non executive director and scheduling a special call to update investors on its Vision 2028 capital project. See our latest analysis for DRDGOLD. At a share price of $20.94, DRDGOLD has seen its short term momentum cool, with the 90 day share price return down 28.12% and the year to date share price return down 30.94%. This comes even though the 1 year total...

Rising US Treasury yields, renewed pressure from $100 oil, and new tariffs from the Trump administration are putting the spotlight back on big US financial stocks, where balance sheet strength and interest rate sensitivity can quickly matter more than headlines. With expectations building around the Federal Reserve’s next move, some large banks, insurers, and asset managers could find this mix of inflation, bond market moves, and trade tension either helpful or painful. This article explains...

Union Pacific (UNP) has put solid numbers on the board for Q2 2026, with revenue of US$6.9 billion, basic EPS of US$3.36 and net income of US$2.0 billion. On a trailing twelve month basis, revenue sits at US$25.4 billion with basic EPS of US$12.36 and net income of US$7.3 billion. The company has seen quarterly revenue move from US$6.2 billion in Q1 2026 to US$6.9 billion in Q2 2026, alongside basic EPS rising from US$2.87 to US$3.36 over the same period. This gives investors a clear view of...

Elanco Animal Health stock has delivered a 107.8% return over the past three years, yet the current valuation checks and intrinsic value work suggest the shares may still be trading below what the business could be worth on fundamentals. Over the past three years, Elanco Animal Health has returned 107.8%, which puts recent price action front and center for anyone weighing up what is already reflected in the share price. For valuation, the key upside driver is how effectively Elanco Animal...

Progress Software stock has retreated over the past three years. On current checks it does not look obviously expensive or obviously cheap, which puts more weight on how investors read the latest moves around its valuation. The recent agreement to acquire Domo for US$400 million adds a fresh piece to that puzzle for anyone weighing what the current share price implies. Progress Software shares are down about 34.2% over three years, which suggests investors have become more cautious about the...

Aktis Oncology (AKTS) has drawn investor attention after recent trading swings, with the stock down 4% over the past week and around 17% over the past month, despite year-to-date gains. See our latest analysis for Aktis Oncology. The recent 30 day share price return of down 16.8% has cooled earlier gains, even though the 90 day share price return of 12.4% and 6.7% year to date still point to fading, but not fully reversed, momentum for Aktis Oncology around the latest close at $23.89. If you...

Oscar Health stock has delivered a very large 3-year gain, yet the broader valuation checks paint a more mixed picture, with the shares currently screening as undervalued on market multiples but only middling on a composite value score. Over the last 3 years, Oscar Health has returned roughly 2.8x an investor's starting position. This puts recent moves in a longer-term context that matters for today's entry price. Expectations around how efficiently Oscar Health can scale its insurance...